Analysis of Cytokines in Response to Treatment of Diabetic Macular Edema With 0.3mg Lucentis
Clinical trial NCT03097068 · COMPLETED
Trial details
- NCT number
- NCT03097068
- Sponsor
- Vitreo-Retinal Associates, Michigan
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-19
- Primary completion
- 2017-12-06
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.